Best Pancreatic neuroendocrine tumors doctors in Israel: TOP 17 doctors

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – Israel's largest sarcoma program.

• Over 41 years of experience specializing in neuroendocrine tumors
• ESMO faculty member for sarcoma treatment
• Fellowship-trained at Institut Gustave Roussy in Paris
• Published extensively on rare tumor treatments

Dr. Pelles Sharon specializes in pancreatic neuroendocrine tumors, offering advanced treatments like Whipple surgery and HIPEC at Sourasky Medical Center.

• Experienced in a wide range of cancer surgeries and therapies
• Conducts clinical research to improve patient understanding of trials
• Provides personalized treatment plans including immunotherapy and targeted therapy

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Heads the Medical Oncology Division at Israel's Sourasky Medical Center – one of the country's major university hospitals.

• Specialized in internal medicine and medical oncology at Sheba Medical Center
• Holds a degree from Ben Gurion University of the Negev
• Speaks fluent English, making international consultations smooth

Leader of the Israeli National Genomic Medicine Initiative – Dr. Raphael specializes in advanced genomic profiling for pancreatic neuroendocrine tumors at Sourasky Medical Center.

• Senior lecturer at Tel Aviv University's Faculty of Medicine
• Primary investigator for multiple clinical trials in oncology
• Expert in liquid biopsies and comprehensive tumor genomic profiling
• Member of European Society of Medical Oncology and IASLC

Heads the Colorectal Surgery Department at Sourasky Medical Center – a top specialist in Whipple surgery for pancreatic neuroendocrine tumors.

• Over 35 years of experience of experience as an abdominal surgeon
• Performs both open and minimally invasive surgical procedures
• Expert in the complex Whipple (pancreaticoduodenectomy) technique

Irina Stepfansky is the director of oncology hospitalization at Tel Aviv Medical Center (Ichilov) – a leading JCI-accredited hospital in Israel.

• Over 26 years of experience of medical experience since starting practice
• Specialized training in oncology at Ichilov's prominent department
• Works as a primary researcher in phase I-III clinical trials for new cancer drugs
• Board-certified in both internal medicine and clinical oncology

Dr. Inna Ospovat is a leading specialist in Lutetium-177 PRRT, pioneering this breakthrough therapy globally.

• Heads the nuclear therapy department at Ichilov – one of few centers offering this treatment
• Specialized in oncology and radiation therapy at Hadassah University Hospital
• Member of ASTRO and Israel Society of Clinical Oncology
• Expert in radiobiological treatments for gastrointestinal tumors

One of the best Whipple surgeons in Israel, Dr. Klauzner chairs the Surgery Department at Sourasky Medical Center.

• Over 42 years of experience of surgical experience
• Specializes in complex colorectal and pancreatic procedures
• Extensive expertise in gastrointestinal cancer surgery
• Leads a top surgical team at a major Tel Aviv hospital

Dr. Auala Hubert is Head of the Gastrointestinal Cancer Center at Hadassah Medical Center – specializing in digestive system cancers.

• 36 years of experience of experience as a medical oncologist and radiotherapist
• Trained in psychology at Hebrew University – adds a human touch to cancer care
• Board certified in both Oncology and Radiotherapy
• Active member of Israel's Committee for Gastrointestinal Cancer

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.